Myelodysplastic Syndrome Revealed by Systems Immunology in a Melanoma Patient Undergoing Anti-PD-1 Therapy.

Greenplate AR, Johnson DB, Roussel M, Savona MR, Sosman JA, Puzanov I, Ferrell PB, Irish JM
Cancer Immunol Res. 2016 4 (6): 474-480

PMID: 26966176 · PMCID: PMC4891280 · DOI:10.1158/2326-6066.CIR-15-0213

MeSH Terms (13)

Aged Anemia, Refractory, with Excess of Blasts Antibodies, Monoclonal, Humanized Antineoplastic Agents Disease Progression Female Flow Cytometry Follow-Up Studies Humans Immunophenotyping Melanoma Myelodysplastic Syndromes Programmed Cell Death 1 Receptor

Connections (6)

This publication is referenced by other Labnodes entities: